{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-108900","form_type":"8-K","ticker":"NEOG","cik":"0000711377","company_name":"NEOGEN CORP","filed_at":"2025-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.201870+00:00","generated_at":"2026-05-17T13:44:59.422322+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Neogen announces board retirement of William Boehm, appointment of Avi Pelossof effective Oct 23/24","bullets":["William T. Boehm to retire from Neogen's Board effective Oct 23, 2025; served since 2011, chairs Audit Committee, member of Compensation & Talent Management Committee.","Avi Pelossof appointed to Board effective Oct 24, 2025 as Class II director; over 25 yrs in diagnostics market, most recently CEO of Immucor.","Pelossof previously Global President, Infectious Disease at Alere Inc., building a $750M portfolio and launching FDA CLIA-waived point-of-care test (now Abbott's ID NOW).","Pelossof will participate in Neogen's non-employee director compensation program as described in 2024 proxy."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-108900","json":"https://secwatch.observer/filing/0000950170-25-108900.json","markdown":"https://secwatch.observer/filing/0000950170-25-108900.md","text":"https://secwatch.observer/filing/0000950170-25-108900.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/711377/000095017025108900/0000950170-25-108900-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/711377/000095017025108900/neog-20250814.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T13:44:59.422322+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}